Journal article
Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis
Cell reports (Cambridge), Vol.11(8), pp.1220-1235
05/26/2015
DOI: 10.1016/j.celrep.2015.04.037
PMCID: PMC4449334
PMID: 25981038
Abstract
Insulin and insulin-like growth factor 1 (IGF-1) are major regulators of muscle protein and glucose homeostasis. To determine how these pathways interact, we generated mice with muscle-specific knockout of IGF-1 receptor (IGF1R) and insulin receptor (IR). These MIGIRKO mice showed >60% decrease in muscle mass. Despite a complete lack of insulin/IGF-1 signaling in muscle, MIGIRKO mice displayed normal glucose and insulin tolerance. Indeed, MIGIRKO mice showed fasting hypoglycemia and increased basal glucose uptake. This was secondary to decreased TBC1D1 resulting in increased Glut4 and Glut1 membrane localization. Interestingly, overexpression of a dominant-negative IGF1R in muscle induced glucose intolerance in MIGIRKO animals. Thus, loss of insulin/IGF-1 signaling impairs muscle growth, but not whole-body glucose tolerance due to increased membrane localization of glucose transporters. Nonetheless, presence of a dominant-negative receptor, even in the absence of functional IR/IGF1R, induces glucose intolerance, indicating that interactions between these receptors and other proteins in muscle can impair glucose homeostasis.
Details
- Title: Subtitle
- Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis
- Creators
- Brian T O'Neill - Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USAHans P M M Lauritzen - Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USAMichael F Hirshman - Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USAGraham Smyth - Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USALaurie J Goodyear - Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USAC Ronald Kahn - Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address: c.ronald.kahn@joslin.harvard.edu
- Resource Type
- Journal article
- Publication Details
- Cell reports (Cambridge), Vol.11(8), pp.1220-1235
- DOI
- 10.1016/j.celrep.2015.04.037
- PMID
- 25981038
- PMCID
- PMC4449334
- NLM abbreviation
- Cell Rep
- ISSN
- 2211-1247
- eISSN
- 2211-1247
- Grant note
- R01 DK031036 / NIDDK NIH HHS P30 DK036836 / NIDDK NIH HHS R01AR42238 / NIAMS NIH HHS R01 DK033201 / NIDDK NIH HHS K08DK100543 / NIDDK NIH HHS UL1 TR000135 / NCATS NIH HHS U24DK100469 / NIDDK NIH HHS K08 DK100543 / NIDDK NIH HHS R01 AR042238 / NIAMS NIH HHS R37 DK031036 / NIDDK NIH HHS U24 DK100469 / NIDDK NIH HHS P30 DK36836 / NIDDK NIH HHS
- Language
- English
- Date published
- 05/26/2015
- Academic Unit
- Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984094551102771
Metrics
21 Record Views